首页 | 本学科首页   官方微博 | 高级检索  
     

非小细胞肺癌术后辅助化疗现状与展望
引用本文:支修益,张毅. 非小细胞肺癌术后辅助化疗现状与展望[J]. 肿瘤研究与临床, 2006, 18(6): 361-363
作者姓名:支修益  张毅
作者单位:1. 100053,北京,首都医科大学肺癌诊疗中心
2. 100053,北京,首都医科大学宣武医院胸外科
摘    要: 非小细胞肺癌(NSCLC)术后辅助化疗出现于20世纪70年代,随着各种新药及新的联合化疗方案的出现,NSCLC的术后辅助化疗亦在不断地进展,越来越多的证据显示术后辅助化疗能提高NSCLC患者的生存期生活质量,就NSCLC的术后辅助化疗现状进行了介绍并对其发展前景进展的展望。

关 键 词:非小细胞肺癌  术后辅助化疗
文章编号:1006-9801(2006)06-0361-03
收稿时间:2005-12-30
修稿时间:2005-12-30

The present situation and prospects of post-operative adjuvant chemotherapy for non-small cell lung cancer
ZHI Xiu-yi,ZHANG Yi. The present situation and prospects of post-operative adjuvant chemotherapy for non-small cell lung cancer[J]. Cancer Research and Clinic, 2006, 18(6): 361-363
Authors:ZHI Xiu-yi  ZHANG Yi
Affiliation:Diagnostic and Therapeutic Center of Lung Cancer, The Capital University of Medical Sciences, and Department of Chest Surgery, Xuanwu Hospital of the Capital University of Medical Sciences, Beijing 100053, China
Abstract:The post-operative adjuvant chemotherapy(PAC) for non-small cell lung cancer(NSCLC) appeared on the 1970s of the 20th century. Along with the appearance of each kind of new drugs and new combined therapeutic regimen, PAC for NSCLC is also progressed gradually, and more and more evidence showed that PAC can improve the survival and quality of life of patients with NSCLC. The present situation of PAC for NSCLC and the prospects of its future development were introduced.
Keywords:Post-operative adjuvant chemotherapy   Non-small cell lung cancer
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《肿瘤研究与临床》浏览原始摘要信息
点击此处可从《肿瘤研究与临床》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号